A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Prof Peter Johnson
University Hospital Southampton NHS Foundation Trust
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
109 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kantonsspital Aarau
Aarau, Switzerland
- Kantonsspital Liestal
Basel, Switzerland
- Universitatsspital Basel
Basel, Switzerland
- Ospedale Regionale Bellinzona E Valli (iosi)
Bellinzona, Switzerland
- Inselspital Bern
Bern, Switzerland
- Stsag Thun
Bern, Switzerland
- Spitalzenturm Oberwallis
Brig, Switzerland
- Kantonsspital Graubunden
Chur, Switzerland
- Luzerner Kantonsspital
Lucerne, Switzerland
- Kantonsspital Olten
Olten, Switzerland
- Kantonsspital St. Gallen
Sankt Gallen, Switzerland
- Stadtspital Triemli
Zurich, Switzerland
- Universitatsspital Zurich
Zurich, Switzerland
- University Hospital Aintree
Aintree, United Kingdom
- Monklands, Hairmyres and Whishaw Hospitals
Airdrie, United Kingdom
- Antrim Area Hospital
Antrim, United Kingdom
- Stoke Mandeville Hospital and Wycombe Hospital
Aylesbury, United Kingdom
- Ysbyty Gwynedd Hospital
Bangor, United Kingdom
- Basildon Hospital
Basildon, United Kingdom
- North Hampshire & Basingstoke Hospital
Basingstoke, United Kingdom
- Royal United Hospital
Bath, United Kingdom
- Belfast City Hospital
Belfast, United Kingdom
- Arrowe Park
Birkenhead, United Kingdom
- Good Hope Hosptial
Birmingham, United Kingdom
- Queen Elizabeth Hospital
Birmingham, United Kingdom
- Sandwell General Hospital Birmingham
Birmingham, United Kingdom
- Victoria Hospital
Blackpool, United Kingdom
- Royal Bournemouth
Bournemouth, United Kingdom
- Bradford Royal Infirmary
Bradford, United Kingdom
- Queen'S Hospital Burton
Burton-on-Trent, United Kingdom
- West Suffolk Hospital
Bury St Edmunds, United Kingdom
- Velindre Hospital
Cardiff, United Kingdom
- Broomfield Hospital
Chelmsford, United Kingdom
- Cheltenham General Hospital and Gloucestershire Royal Infirmary
Cheltenham, United Kingdom
- Chesterfield Royal
Chesterfield, United Kingdom
- St Richard'S Hospital
Chichester, United Kingdom
- Colchester General Hospital
Colchester, United Kingdom
- University Hospital Coventry
Coventry, United Kingdom
- Darent Valley Hospital
Dartford, United Kingdom
- Royal Derby Hospitals
Derby, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2011
- Primary completion
- 30 Apr 2015
- Completion
- 30 Jun 2015
- Last update posted
- 15 Apr 2016
- Registered enrollment
- 1,132
- Registry id
- NCT01324596
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.